Keiichi Kuwano

429 total citations
9 papers, 358 citations indexed

About

Keiichi Kuwano is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Keiichi Kuwano has authored 9 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pharmacology. Recurrent topics in Keiichi Kuwano's work include Pulmonary Hypertension Research and Treatments (5 papers), Nitric Oxide and Endothelin Effects (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Keiichi Kuwano is often cited by papers focused on Pulmonary Hypertension Research and Treatments (5 papers), Nitric Oxide and Endothelin Effects (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Keiichi Kuwano collaborates with scholars based in Japan and Switzerland. Keiichi Kuwano's co-authors include Kenji Kuwabara, Taisuke Hamamoto, Tetsuo Asaki, Asami Hashino, Tetsuhiro Yamada, Kumiko Noda, John Gatfield, Keith Morrison, Martine Clozel and Yukiteru Sugiyama and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Keiichi Kuwano

9 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichi Kuwano Japan 6 224 160 67 61 43 9 358
Tetsuhiro Yamada Japan 6 161 0.7× 113 0.7× 59 0.9× 44 0.7× 17 0.4× 20 281
Keith Morrison Switzerland 9 355 1.6× 344 2.1× 121 1.8× 145 2.4× 54 1.3× 16 696
Hiroshi Akutsu Japan 12 62 0.3× 141 0.9× 129 1.9× 69 1.1× 160 3.7× 39 511
Chung-hsin Ts’ao United States 13 120 0.5× 87 0.5× 139 2.1× 56 0.9× 14 0.3× 22 419
Christopher L. Heran United States 14 37 0.2× 162 1.0× 121 1.8× 30 0.5× 48 1.1× 22 503
H. Narjes Germany 11 84 0.4× 69 0.4× 111 1.7× 26 0.4× 75 1.7× 17 461
Chun Song Japan 6 158 0.7× 58 0.4× 77 1.1× 78 1.3× 73 1.7× 14 361
Peter B. Ehmer Germany 8 99 0.4× 46 0.3× 176 2.6× 9 0.1× 86 2.0× 12 584
Thomas E. Steinbacher United States 15 36 0.2× 180 1.1× 100 1.5× 56 0.9× 38 0.9× 30 469
H Weisenberger Germany 13 41 0.2× 214 1.3× 82 1.2× 42 0.7× 38 0.9× 21 463

Countries citing papers authored by Keiichi Kuwano

Since Specialization
Citations

This map shows the geographic impact of Keiichi Kuwano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichi Kuwano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichi Kuwano more than expected).

Fields of papers citing papers by Keiichi Kuwano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichi Kuwano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichi Kuwano. The network helps show where Keiichi Kuwano may publish in the future.

Co-authorship network of co-authors of Keiichi Kuwano

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichi Kuwano. A scholar is included among the top collaborators of Keiichi Kuwano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichi Kuwano. Keiichi Kuwano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Kuwano, Keiichi, et al.. (2020). The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats. PLoS ONE. 15(10). e0240692–e0240692. 8 indexed citations
3.
4.
Asaki, Tetsuo, Keiichi Kuwano, Keith Morrison, et al.. (2015). Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension. Journal of Medicinal Chemistry. 58(18). 7128–7137. 69 indexed citations
5.
6.
Asaki, Tetsuo, Taisuke Hamamoto, Yukiteru Sugiyama, Keiichi Kuwano, & Kenji Kuwabara. (2007). Structure–activity studies on diphenylpyrazine derivatives: A novel class of prostacyclin receptor agonists. Bioorganic & Medicinal Chemistry. 15(21). 6692–6704. 45 indexed citations
7.
Asaki, Tetsuo, Taisuke Hamamoto, Yukiteru Sugiyama, et al.. (2007). Structure–activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(23). 6588–6592. 5 indexed citations
8.
Kuwano, Keiichi, Asami Hashino, Tetsuo Asaki, et al.. (2007). 2-{4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), an Orally Available and Long-Acting Prostacyclin Receptor Agonist Prodrug. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1181–1188. 141 indexed citations
9.
Minatoguchi, Shinya, Yoshihiro Uno, Yoshio Nishida, et al.. (2001). Role of protein kinase C in the reduction of infarct size by N‐methyl‐1‐deoxynojirimycin, an α‐1,6‐glucosidase inhibitor. British Journal of Pharmacology. 133(5). 635–642. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuhiro Yamada Breakdown of academic impact, for papers by Keith Morrison Breakdown of academic impact, for papers by Hiroshi Akutsu Breakdown of academic impact, for papers by Chung-hsin Ts’ao Breakdown of academic impact, for papers by Christopher L. Heran Breakdown of academic impact, for papers by H. Narjes Breakdown of academic impact, for papers by Chun Song Breakdown of academic impact, for papers by Peter B. Ehmer Breakdown of academic impact, for papers by Thomas E. Steinbacher Breakdown of academic impact, for papers by H Weisenberger
Rankless by CCL
2026